A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study led by Western researchers suggests that frequent treatment with intranasal oxytocin—a hormone linked to empathy—may help reduce apathy in patients with frontotemporal dementia (FTD).